Browse the corpus

REFERENCES Aronoff GR, Bennett WM, Berns JS, et al, Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 97, 169. Centers for Disease Control and Prevention, “Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics,” MMWR Recomm Rep , 2009, 58(RR-11):1-166. Available at file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf [PubMed 19730409 ] Centers for Disease Control and Prevention, “Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America,” MMWR Recomm Rep , 2009, 58(4):1-207. [PubMed 19357635 ] Chapman SW, Dismukes WE, Proia LA, et al, "Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2008, 46(12):1801-12. [PubMed 18462107 ] De Marie S, “Clinical Use of Liposomal and Lipid-Complexed Amphotericin B,” J Antimicrob Chemother , 1994, 33(5):907-16. [PubMed 8089064 ] Edwards JE Jr, Bodey GP, Bowden RA, et al, “International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections,” Clin Infect Dis , 1997, 25(1):43-59. [PubMed 9243032 ] Galgiani JN, Ampel NM, Blair JE, et al, "Coccidioidomycosis," Clin Infect Dis , 2005, 41(9):1217-23. [PubMed 16206093 ] Gould FK, Denning DW, Elliott TS, et al, “Guidelines for the Diagnosis and Antibiotic Treatment of Endocarditis in Adults: A Report of the Working Party of the British Society for Antimicrobial Chemotherapy,” J Antimicrob Chemother , 2012, 67(2):269-89. [PubMed 22086858 ] Hiemenz JW and Walsh TJ, “Lipid Formulations of Amphotericin B: Recent Progress and Future Directions,” Clin Infect Dis , 1996, 22(Suppl 2):133-44. [PubMed 8824978 ] Hooshmand-Rad R, Chu A, Gotz V, et al, "Use of Amphotericin B Lipid Complex in Elderly Patients," J Infect , 2005, 50(4):277-87. [PubMed 15845425 ]

Gould FK, Denning DW, Elliott TS, et al, “Guidelines for the Diagnosis and Antibiotic Treatment of Endocarditis in Adults: A Report of the Working Party of the British Society for Antimicrobial Chemotherapy,” J Antimicrob Chemother , 2012, 67(2):269-89. [PubMed 22086858 ] Hiemenz JW and Walsh TJ, “Lipid Formulations of Amphotericin B: Recent Progress and Future Directions,” Clin Infect Dis , 1996, 22(Suppl 2):133-44. [PubMed 8824978 ] Hooshmand-Rad R, Chu A, Gotz V, et al, "Use of Amphotericin B Lipid Complex in Elderly Patients," J Infect , 2005, 50(4):277-87. [PubMed 15845425 ] Kauffman CA, Bustamante B, Chapman SW, et al, "Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2007, 45(10):1255-65. [PubMed 17968818 ] King CT, Rogers PD, Cleary JD, et al, "Antifungal Therapy During Pregnancy," Clin Infect Dis , 1998, 27(5):1151-60. [PubMed 9827262 ] Kline S, Larsen TA, Fieber L, et al, “Limited Toxicity of Prolonged Therapy With High Doses of Amphotericin B Lipid Complex,” Clin Infect Dis , 1995, 21(5):1154-8. [PubMed 8589135 ] Mactal-Haaf C, Hoffman M, and Kuchta A, "Use of Anti-infective Agents During Lactation, Part 3: Antivirals, Antifungals, and Urinary Antiseptics," J Hum Lact , 2001, 17(2):160-6. [PubMed 11847833 ] Mora-Duarte J, Betts R, Rotstein C, et al, “Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis,” N Engl J Med , 2002, 347(25):2020-9. [PubMed 12490683 ] Pappas PG, Kauffman CA, Andes D, et al, "Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2009, 48(5):503-35. [PubMed 19191635 ] Perfect JR, Dismukes WE, Dromer F, et al, "Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2010, 50(3):291-322. [PubMed 20047480 ] Rapp RP, Gubbins PO, and Evans ME, “Amphotericin B Lipid Complex,” Ann Pharmacother , 1997, 31(10):1174-86. [PubMed 9337444 ] Rex JH, Pappas PG, Karchmer AW, et al, “A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole Plus Placebo Versus Fluconazole Plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects,” Clin Infect Dis , 2003, 36(10):1221-8. [PubMed 12746765 ]

Rapp RP, Gubbins PO, and Evans ME, “Amphotericin B Lipid Complex,” Ann Pharmacother , 1997, 31(10):1174-86. [PubMed 9337444 ] Rex JH, Pappas PG, Karchmer AW, et al, “A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole Plus Placebo Versus Fluconazole Plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects,” Clin Infect Dis , 2003, 36(10):1221-8. [PubMed 12746765 ] Sacks GS and Cleary JD, “Nutritional Impact of Lipid-Associated Amphotericin B Formulations,” Ann Pharmacother , 1997, 31(1):121-2. [PubMed 8997484 ] Slain D, “Lipid-Based Amphotericin B for the Treatment of Fungal Infections,” Pharmacotherapy , 1999, 19(3):306-23. [PubMed 10221369 ] Walsh TJ, Anaissie EJ, Denning DW, et al, “Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America,” Clin Infect Dis , 2008, 46(3):327-60. [PubMed 18177225 ] Wheat LJ, Freifeld AG, Kleiman MB, et al, "Clinical Practice Guidelines for the Management of Patients With Histoplasmosis: 2007 Update by the Infectious Diseases Society of America," Clin Infect Dis , 2007, 45(7):807-25. [PubMed 17806045 ] Topic 8724 Version 37.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1005-183.1.191.153-B28792CD2A-S244013.14]